Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 12
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05234775 | Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product | ||
| NCT03549260 | Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction | ||
| NCT04034485 | Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH | ||
| NCT04797104 | Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction | ||
| NCT04790513 | Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients | ||
| NCT04806893 | Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction | ||
| NCT04797247 | Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction | ||
| NCT03545438 | Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 | ||
| NCT04798430 | Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction | ||
| NCT07102511 | Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH | ||
| NCT05004675 | Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients | ||
| NCT03847974 | Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 |
